“The acquisition is an important step in expanding Angus’ leadership position in life sciences beyond bio buffers into specialty cell culture media, a strategic adjacency with high customer overlap and complementary product and service offerings," the Buffalo Grove, Illinois-headquartered company said.

With its central headquarters in Davis, California, Expression Services is cGMP-compliant and ISO 13485 certified for its manufacturing and research activities.

"The combination of the two companies further strengthens our ability to deliver value through the consistent, high-quality ingredients and services essential to all phases of bioprocessing, from early-stage biologics development to full-scale commercial production, said David Neuberger, Angus’ president and CEO.

The California company specializes in baculovirus expression vector system (BEVS) and has deep expertise across the process from gene optimization to protein purification. Its products are used primarily by structural biology researchers and biologics manufacturers to produce certain drug candidates, protein-based therapies, vaccines and gene therapies efficiently and cost-effectively.

David Hedin, Expression Systems’ CEO, said that being acquired by Angus will enhance his company’s status as a dedicated supplier of the biologics industry segments employing the baculovirus expression platform.

Angus is known for its nitroalkane chemistries, including its flagship AMPTM (aminomethyl propanol) multifunctional additives and Tris Amino (tromethamine) buffers, which it produces at its fully integrated, ISO 9001-certified manufacturing facilities in the US and Germany, and its six regional Customer Application Centers in Chicago, Illinois, USA; Paris, France, São Paulo, Brazil, Singapore; Shanghai, China, and Mumbai, India.

The company is privately owned by Ardian and Golden Gate Capital.

Author: Dede Williams, Freelance Journalist